BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28105116)

  • 1. Computer-assisted quantitative evaluation of bisphosphonate treatment for Paget's disease of bone using the bone scan index.
    Nagano S; Nakamura S; Shimada H; Yokouchi M; Setoguchi T; Ishidou Y; Sasaki H; Komiya S
    Exp Ther Med; 2016 Dec; 12(6):3830-3836. PubMed ID: 28105116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
    Papapoulos SE; Frölich M
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of a computer-assisted diagnostic system: sensitivity of BONENAVI for bone scintigraphy in patients with disseminated skeletal metastasis is not so high.
    Koizumi M; Motegi K; Koyama M; Ishiyama M; Togawa T; Makino T; Arisaka Y; Terauchi T
    Ann Nucl Med; 2020 Mar; 34(3):200-211. PubMed ID: 31970706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone.
    Reid IR; Davidson JS; Wattie D; Wu F; Lucas J; Gamble GD; Rutland MD; Cundy T
    Bone; 2004 Jul; 35(1):224-30. PubMed ID: 15207761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical assessment of Paget's disease of bone.
    Shankar S; Hosking DJ
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P22-7. PubMed ID: 17229003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Vidal S; Ros I; Monegal A; Bedini JL; Deulofeu R; Pons F; Muñoz-Gomez J; Ballesta AM
    Bone; 2001 Nov; 29(5):447-52. PubMed ID: 11704497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
    Al Nofal AA; Altayar O; BenKhadra K; Qasim Agha OQ; Asi N; Nabhan M; Prokop LJ; Tebben P; Murad MH
    Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
    Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of diagnostic precision for bone metastasis of primary breast cancer between BONENAVI version 1 and BONENAVI version 2.
    Okada Y; Matsushita S; Nakajima Y; Yamaguchi K; Okuda I; Kojima Y; Tsugawa K
    Nucl Med Commun; 2019 Nov; 40(11):1148-1153. PubMed ID: 31469804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
    Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S
    Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the Different Primary Cancers and Different Types of Bone Metastasis on the Lesion-based Artificial Neural Network Value Calculated by a Computer-aided Diagnostic System, BONENAVI, on Bone Scintigraphy Images.
    Isoda T; BaBa S; Maruoka Y; Kitamura Y; Tahara K; Sasaki M; Hatakenaka M; Honda H
    Asia Ocean J Nucl Med Biol; 2017; 5(1):49-55. PubMed ID: 28840139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
    Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
    Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of bone scan index change over time on automated calculation in bone scintigraphy.
    Shintawati R; Achmad A; Higuchi T; Shimada H; Hirasawa H; Arisaka Y; Takahashi A; Nakajima T; Tsushima Y
    Ann Nucl Med; 2015 Dec; 29(10):911-20. PubMed ID: 26373556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tartrate-resistant acid phosphatase 5b, but not periostin, is useful for assessing Paget's disease of bone.
    Guañabens N; Filella X; Florez H; Ruiz-Gaspá S; Conesa A; Peris P; Monegal A; Torres F
    Bone; 2019 Jul; 124():132-136. PubMed ID: 31051316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate.
    Filipponi P; Cristallini S; Policani G; Casciari C; Gregorio F
    Bone; 1998 Dec; 23(6):543-8. PubMed ID: 9855463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
    Pons F; Alvarez L; Peris P; Guañabens N; Vidal-Sicart S; Monegal A; Pavía J; Ballesta AM; Muños-Gómez J; Herranz R
    Nucl Med Commun; 1999 Jun; 20(6):525-8. PubMed ID: 10451864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of monostotic Paget's disease: effects of bisphosphonate.
    Hoshiro M; Harada T; Iwai H; Miyatake T; Nishimura A; Ohno Y; Aoki N
    Endocr J; 2003 Aug; 50(4):385-92. PubMed ID: 14599111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy.
    Peris P; Alvarez L; Vidal S; Martínez MA; Monegal A; Guañabens N
    Clin Exp Rheumatol; 2007; 25(2):206-10. PubMed ID: 17543143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients.
    Maeno Y; Inaba M; Okuno S; Yamakawa T; Ishimura E; Nishizawa Y
    Clin Chem; 2005 Dec; 51(12):2312-7. PubMed ID: 16223890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.